Variant report
Variant | nsv967188 |
---|---|
Chromosome Location | chr3:146483866-146491983 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:146477908..146479521-chr3:146482688..146484661,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs528069828 | chr3:146486015-146486016 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs550974073 | chr3:146486016-146486017 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs533318805 | chr3:146486056-146486057 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs78095108 | chr3:146486091-146486092 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs563718729 | chr3:146486115-146486116 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs575839369 | chr3:146486174-146486175 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs75340520 | chr3:146486205-146486206 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs542853337 | chr3:146486210-146486211 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs567335448 | chr3:146486211-146486212 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs529943719 | chr3:146486219-146486220 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs190608908 | chr3:146486364-146486365 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs529016062 | chr3:146486365-146486366 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs547392100 | chr3:146486381-146486382 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs144646249 | chr3:146486393-146486394 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs530563101 | chr3:146486802-146486803 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs533249420 | chr3:146486810-146486811 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs543949931 | chr3:146486811-146486812 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs561085033 | chr3:146486825-146486826 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs529906190 | chr3:146486857-146486858 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs187084792 | chr3:146486876-146486877 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs140643032 | chr3:146486891-146486892 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs374515864 | chr3:146486954-146486955 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs532470006 | chr3:146486982-146486983 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs552507980 | chr3:146486999-146487000 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs143514726 | chr3:146487008-146487009 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs374696454 | chr3:146487040-146487041 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs551696410 | chr3:146487061-146487062 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs150024979 | chr3:146487095-146487096 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs566781303 | chr3:146487106-146487107 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs192461417 | chr3:146487133-146487134 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs79141789 | chr3:146487175-146487176 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs568227334 | chr3:146487177-146487178 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs570691364 | chr3:146488000-146488001 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs548920517 | chr3:146488025-146488026 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs540072256 | chr3:146488040-146488041 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs7617943 | chr3:146488110-146488111 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs372513217 | chr3:146488122-146488123 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs530212905 | chr3:146488129-146488130 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs7617957 | chr3:146488134-146488135 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs368781200 | chr3:146488157-146488158 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs554624761 | chr3:146488164-146488165 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs574550273 | chr3:146488171-146488172 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs540313294 | chr3:146488201-146488202 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs137952966 | chr3:146488258-146488259 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs567394283 | chr3:146488273-146488274 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs9289731 | chr3:146488309-146488310 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs552931115 | chr3:146488346-146488347 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs9289732 | chr3:146488356-146488357 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs562595827 | chr3:146488368-146488369 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs531657604 | chr3:146488410-146488411 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Colorectal cancer | 18645599 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Blepharophimosis-ptosis-epicanthus inversus syndrome | 22067867 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Mental retardation | 17847001 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Autism | 18923514 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Autism | 21956041 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Breast cancer | 16608533 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:146486000-146486400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr3:146486000-146486400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr3:146486800-146487200 | Enhancers | Dnd41 | blood |
4 | chr3:146488000-146489800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
5 | chr3:146489800-146490600 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr3:146490000-146490600 | ZNF genes & repeats | Foreskin Fibroblast Primary Cells skin01 | Skin |
7 | chr3:146490600-146498800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |